These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23291938)

  • 1. Confocal microscopy study of pertussis toxin and toxoids on CHO-cells.
    Tan Y; Fleck RA; Asokanathan C; Yuen CT; Xing D; Zhang S; Wang J
    Hum Vaccin Immunother; 2013 Feb; 9(2):332-8. PubMed ID: 23291938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of formaldehyde, hydrogen peroxide and genetic detoxification of pertussis toxin on epitope recognition by murine monoclonal antibodies.
    Ibsen PH
    Vaccine; 1996 Apr; 14(5):359-68. PubMed ID: 8735545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of different detoxification procedures on the residual pertussis toxin activities in vaccines.
    Yuen CT; Asokanathan C; Cook S; Lin N; Xing D
    Vaccine; 2016 Apr; 34(18):2129-34. PubMed ID: 26973066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calibration of pertussis toxin BRP batch 1 in a standardised CHO cell-based clustering assay.
    Markey K; Douglas-Bardsley A; Hockley J; Le Tallec D; Costanzo A
    Pharmeur Bio Sci Notes; 2018; 2018():112-123. PubMed ID: 30272557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a carbohydrate binding assay for the B-oligomer of pertussis toxin and toxoid.
    Gomez SR; Xing DK; Corbel MJ; Coote J; Parton R; Yuen CT
    Anal Biochem; 2006 Sep; 356(2):244-53. PubMed ID: 16782039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically detoxified pertussis toxin (PT-9K/129G): implications for immunization and vaccines.
    Seubert A; D'Oro U; Scarselli M; Pizza M
    Expert Rev Vaccines; 2014 Oct; 13(10):1191-204. PubMed ID: 25183193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetically detoxified pertussis toxin displays near identical structure to its wild-type and exhibits robust immunogenicity.
    Ausar SF; Zhu S; Duprez J; Cohen M; Bertrand T; Steier V; Wilson DJ; Li S; Sheung A; Brookes RH; Pedyczak A; Rak A; Andrew James D
    Commun Biol; 2020 Aug; 3(1):427. PubMed ID: 32759959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel process for preparing an acellular pertussis vaccine composed of non-pyrogenic toxoids of pertussis toxin and filamentous hemagglutinin.
    Tan LU; Fahim RE; Jackson G; Phillips K; Wah P; Alkema D; Zobrist G; Herbert A; Boux L; Chong P
    Mol Immunol; 1991 Mar; 28(3):251-5. PubMed ID: 2017196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetically derived toxoids for use as vaccines and adjuvants.
    Del Giudice G; Rappuoli R
    Vaccine; 1999 Oct; 17 Suppl 2():S44-52. PubMed ID: 10506408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of a safe, potent and immunogenic partially purified acellular pertussis vaccine using simple indigenous techniques.
    Gupta RK; Saxena SN; Sharma SB; Ahuja S
    Dev Biol Stand; 1991; 73():205-22. PubMed ID: 1778314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collaborative study for the standardisation of the histamine sensitizing test in mice and the CHO cell-based assay for the residual toxicity testing of acellular pertussis vaccines.
    Xing D; Maes A; Behr-Gross ME; Costanzo A; Daas A; Buchheit KH
    Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):51-63. PubMed ID: 20223190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The reaction of bacterial toxins with formaldehyde and its use for antigen stabilization.
    Petre J; Pizza M; Nencioni L; Podda A; De Magistris MT; Rappuoli R
    Dev Biol Stand; 1996; 87():125-34. PubMed ID: 8854009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of xCELLigence real-time cell analysis to the microplate assay for pertussis toxin induced clustering in CHO cells.
    Bernardo L; Corallo L; Caterini J; Su J; Gisonni-Lex L; Gajewska B
    PLoS One; 2021; 16(3):e0248491. PubMed ID: 33720984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collaborative study for the calibration of the replacement International Standard for pertussis toxin for use in histamine sensitisation and CHO cell clustering assays.
    Douglas-Bardsley A; Asokanathan C; Tierney S; Hockley J; Markey K
    Biologicals; 2019 Nov; 62():85-92. PubMed ID: 31526657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children. Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine.
    Podda A; Bona G; Canciani G; Pistilli AM; Contu B; Furlan R; Meloni T; Stramare D; Titone L; Rappuoli R
    J Pediatr; 1995 Aug; 127(2):238-43. PubMed ID: 7636648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humanised monoclonal antibodies neutralise pertussis toxin by receptor blockade and reduced retrograde trafficking.
    Acquaye-Seedah E; Huang Y; Sutherland JN; DiVenere AM; Maynard JA
    Cell Microbiol; 2018 Dec; 20(12):e12948. PubMed ID: 30152075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reporter cell lines for detection of pertussis toxin in acellular pertussis vaccines as a functional animal-free alternative to the in vivo histamine sensitization test.
    Hoonakker ME; Verhagen LM; van der Maas L; Sloots A; Hendriksen CFM
    Vaccine; 2017 Feb; 35(8):1152-1160. PubMed ID: 28129894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lectin-like binding of pertussis toxin to a 165-kilodalton Chinese hamster ovary cell glycoprotein.
    Brennan MJ; David JL; Kenimer JG; Manclark CR
    J Biol Chem; 1988 Apr; 263(10):4895-9. PubMed ID: 3350815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transferability study of CHO cell clustering assays for monitoring of pertussis toxin activity in acellular pertussis vaccines.
    Isbrucker R; Daas A; Wagner L; Costanzo A
    Pharmeur Bio Sci Notes; 2016; 2015():97-114. PubMed ID: 27506252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenylate cyclase toxin-mediated delivery of the S1 subunit of pertussis toxin into mammalian cells.
    Iwaki M; Konda T
    Pathog Dis; 2016 Feb; 74(1):ftv110. PubMed ID: 26607401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.